M. Takada et al., BINDING OF BIOTINYLATED THROMBIN RECEPTOR PEPTIDE TO CLONED HUMAN THROMBIN RECEPTOR OVEREXPRESSED IN BABY HAMSTER-KIDNEY CELLS, Journal of receptor and signal transduction research, 15(1-4), 1995, pp. 103-115
Baby hamster kidney (BHK) cells transfected with an expression vector
for the human thrombin receptor, and then treated with basic fibroblas
t growth factor, were found to express specific and saturable binding
sites for biotinylated thrombin receptor peptide (SFLLRNPNDKYEPF). Ana
lysis of the binding to live BHK cells yielded an equilibrium dissocia
tion constant (Kd) of 3.0+/-0.3 mu mol/l and a maximal binding capacit
y (Bmax) of 31.0+/-0.5 nmol/mg of protein. In competitive binding expe
riments, the thrombin receptor agonist peptide (SFLLRN), which is a st
rong inducer of human platelet aggregation, was the most potent compet
itor. In contrast, position 1 to 2 inverted peptides such as FSLLRNPND
KYEPF and FSLLRNP, which fail to induce for the platelet aggregation,
were less potent. This simple and convenient binding assay system usin
g the biotinylated thrombin receptor peptide as a labeled ligand and t
he cloned thrombin receptor overexpressed in BHK cells may be useful f
or exploring specific antagonists of the receptor.